JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB50702

Anti-CREBBP antibody [CBP5I001]

2

(1 Review)

|

(13 Publications)

Mouse Monoclonal CREBBP antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 13 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CREBBP.

View Alternative Names

CBP, CREBBP, CREB-binding protein, Histone lysine acetyltransferase CREBBP, Protein lactyltransferas CREBBP, Protein-lysine acetyltransferase CREBBP

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-CREBBP antibody [CBP5I001] (AB50702)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CREBBP antibody [CBP5I001] (AB50702)

Staining of HeLa cell lysate with ab50702 at a dilution of 1/5 and Goat anti-mouse secondary at 1/200.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREBBP antibody [CBP5I001] (AB50702)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREBBP antibody [CBP5I001] (AB50702)

IHC image of CREBBP staining in human pancreas formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab50702, 10μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)
  • WB

Lab

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)

Lane 1 : Wild-type HAP1 whole cell lysate (40 μg)
Lane 2 : CREBBP knockout HAP1 whole cell lysate (40 μg)
Lane 3 : HeLa whole cell lysate (40 μg)
Lane 4 : NIH3T3 whole cell lysate (40 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab50702 observed at 265 kDa. Red - loading control, ab176560, observed at 50 kDa.

ab50702 was shown to specifically recognize CREBBP in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when CREBBP knockout samples were examined. Wild-type and CREBBP knockout samples were subjected to SDS-PAGE. ab50702 and ab176560 (Rabbit anti-alpha Tubulin loading control) were incubated overnight at 4°C at 1/100 dilution and 1/10,000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed ab216772 and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed ab216777 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CREBBP antibody [CBP5I001] (ab50702)

Predicted band size: 265 kDa

false

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)
  • WB

Unknown

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)

All lanes:

Western blot - Anti-CREBBP antibody [CBP5I001] (ab50702) at 1/30 dilution

All lanes:

RIPA lysate of HeLa cells at 500 µg

Secondary

All lanes:

Mouse IgG antibody at 1/2500 dilution

Predicted band size: 265 kDa

false

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)
  • WB

Unknown

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)

All lanes:

Western blot - Anti-CREBBP antibody [CBP5I001] (ab50702) at 1/100 dilution

All lanes:

HeLa whole cell lysate at 50 µg

Secondary

All lanes:

Mouse IgG antibody at 1/2500 dilution

Predicted band size: 265 kDa

false

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)
  • WB

Unknown

Western blot - Anti-CREBBP antibody [CBP5I001] (AB50702)

All lanes:

Western blot - Anti-CREBBP antibody [CBP5I001] (ab50702) at 1/50 dilution

All lanes:

NIH3T3 whole cell lysate at 50 µg

Secondary

All lanes:

Mouse IgG antibody at 1/2500 dilution

Predicted band size: 265 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

CBP5I001

Isotype

IgG1

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, IHC-P, ICC/IF

applications

Immunogen

Recombinant Full Length Protein corresponding to Human CREBBP.

Q92793

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "10 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/50 - 1/100", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/5", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/50 - 1/100", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
This antibody was purified using protein G column chromatography from culture supernatant of hybridoma cultured in a medium containing bovine IgG depleted(approximately 95%) fetal bovine serum, and filtered through a 0.22 µm membrane.
Storage buffer
pH: 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CREBBP also known as CREB Binding Protein or CBP is a multifunctional protein with a molecular weight of approximately 265 kDa. This protein serves as a transcriptional coactivator and possesses intrinsic histone acetyltransferase (HAT) activity. CREBBP is ubiquitously expressed making it present in various tissues throughout the body. Its interaction with different transcription factors facilitates transcriptional activation by remodeling chromatin structure.
Biological function summary

CREBBP plays a pivotal role in regulating gene expression by serving as a coactivator that bridges transcription factors with the basal transcription machinery. CREBBP as part of large multiprotein complexes acetylates histones as well as non-histone proteins influencing chromatin accessibility and transcriptional efficiency. Its HAT activity contributes to the regulation of cell cycle differentiation and DNA repair.

Pathways

CREBBP integrates into both the p53 and Hedgehog signaling pathways modulating various cellular responses. In the p53 pathway CREBBP interacts with the tumor suppressor protein p53 enhancing p53’s ability to initiate expression of genes involved in cell cycle arrest and apoptosis. In the Hedgehog pathway CREBBP regulates transcription factors such as Gli proteins. The interplay between CREBBP and these pathways underlines its importance in maintaining cellular homeostasis and preventing oncogenesis.

Mutations or dysregulation of CREBBP are associated with Rubinstein-Taybi syndrome and various cancers including acute myeloid leukemia. In Rubinstein-Taybi syndrome CREBBP mutations impair cognitive development and skeletal malformations. In cancer particularly acute myeloid leukemia alterations in CREBBP disrupt normal cell growth regulation and lead to tumorigenesis. The protein's interaction with factors like p300 another histone acetyltransferase further emphasizes its critical involvement in these pathological conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acetylates histones, giving a specific tag for transcriptional activation (PubMed : 21131905, PubMed : 24616510). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed : 21131905). Also acetylates non-histone proteins, like DDX21, FBL, IRF2, MAFG, NCOA3, POLR1E/PAF53 and FOXO1 (PubMed : 10490106, PubMed : 11154691, PubMed : 12738767, PubMed : 12929931, PubMed : 24207024, PubMed : 28790157, PubMed : 30540930, PubMed : 35675826, PubMed : 9707565). Binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1. Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators : NPAS2-BMAL1 and CLOCK-BMAL1 heterodimers (PubMed : 14645221). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed : 24939902). Acetylates POLR1E/PAF53, leading to decreased association of RNA polymerase I with the rDNA promoter region and coding region (PubMed : 24207024). Acetylates DDX21, thereby inhibiting DDX21 helicase activity (PubMed : 28790157). Acetylates FBL, preventing methylation of 'Gln-105' of histone H2A (H2AQ104me) (PubMed : 30540930). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as lactoyl-CoA, and is able to mediate protein lactylation (PubMed : 38128537). Catalyzes lactylation of MRE11 in response to DNA damage, thereby promoting DNA double-strand breaks (DSBs) via homologous recombination (HR) (PubMed : 38128537). Functions as a transcriptional coactivator for SMAD4 in the TGF-beta signaling pathway (PubMed : 25514493).
See full target information CREBBP

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 4:1207 PubMed34675360

2021

Speckles and paraspeckles coordinate to regulate HSV-1 genes transcription.

Applications

Unspecified application

Species

Unspecified reactive species

Kun Li,Ziqiang Wang

Pathology oncology research : POR 27:609620 PubMed34257574

2021

Wnt3a/β-Catenin/CBP Activation in the Progression of Cervical Intraepithelial Neoplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Dingqing Feng,Jie Lin,Wenhui Wang,Keqin Yan,Haiyan Liang,Jing Liang,Huan Yu,Bin Ling

Neoplasia (New York, N.Y.) 23:1-11 PubMed33190089

2020

CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2.

Applications

Unspecified application

Species

Unspecified reactive species

Dingqing Feng,Keqin Yan,Haiyan Liang,Jing Liang,Wenhui Wang,Huan Yu,Ying Zhou,Weidong Zhao,Zhongjun Dong,Bin Ling

Anticancer research 40:5211-5219 PubMed32878809

2020

Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Ryosuke Gabata,Kenichi Harada,Yuki Mizutani,Hirofumi Ouchi,Kaori Yoshimura,Yasunori Sato,Azusa Kitao,Kiminori Kimura,Hiroyuki Kouji,Tomoharu Miyashita,Hidehiro Tajima,Tetsuo Ohta

Journal of experimental & clinical cancer research 38:502 PubMed31870402

2019

HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yangyang Dong,Xinyu Li,Zhibin Lin,Wenbing Zou,Yan Liu,Huiyang Qian,Jing Jia

Cellular and molecular life sciences : CMLS 77:3441-3452 PubMed31838573

2019

Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules.

Applications

Unspecified application

Species

Unspecified reactive species

Ziqiang Wang,Kun Li,Wei Chen,Xiaoxia Wang,Yikun Huang,Weiming Wang,Wanjun Wu,Zhiming Cai,Weiren Huang

Cytokine 123:154742 PubMed31260855

2019

Adipokine zinc-α2-glycoprotein alleviates lipopolysaccharide-induced inflammatory responses through the β3-AR/PKA/CREB pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Guo,Yanfei Li,Ruqian Zhao,Xiaojing Yang

Cellular and molecular life sciences : CMLS 76:3005-3018 PubMed31006037

2019

NEAT1 regulates neuroglial cell mediating Aβ clearance via the epigenetic regulation of endocytosis-related genes expression.

Applications

Unspecified application

Species

Unspecified reactive species

Ziqiang Wang,Yiwan Zhao,Naihan Xu,Shikuan Zhang,Songmao Wang,Yunhao Mao,Yuanchang Zhu,Bing Li,Yuyang Jiang,Ying Tan,Weidong Xie,Burton B Yang,Yaou Zhang

Journal of cellular physiology 234:12839-12846 PubMed30536761

2018

Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell.

Applications

Unspecified application

Species

Unspecified reactive species

Pengzhou Li,Liyong Zhu,Xiangwu Yang,Weizheng Li,Xulong Sun,Bo Yi,Shaihong Zhu

Frontiers in pediatrics 6:382 PubMed30560112

2018

Alteration of the Retinoid Acid-CBP Signaling Pathway in Neural Crest Induction Contributes to Enteric Nervous System Disorder.

Applications

Unspecified application

Species

Unspecified reactive species

Cheng Li,Rong Hu,Nali Hou,Yi Wang,Zhili Wang,Ting Yang,Yan Gu,Mulan He,Yu Shi,Jie Chen,Weihong Song,Tingyu Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com